Skip to content

Sarepta Therapeutics, Inc. SRPT Prepaid & Other Current

Prepaid & Other Current at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$620.9M+32.4%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$205.5M+13.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$66.05M+15.8%
Insmed logo
InsmedINSM
$78.2M+42.7%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$4.48M+217%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$18.77M+33.9%

Other financials

Income statement

See full
Revenue$730.8M-1.9%
Operating income-$300.4M-961%
Net income$331.0M+174%
EPS (diluted)-$4.60-1,343%

Balance sheet

See full
Cash & equivalents$464.5M+92.8%
Total debt$198.5M-3.4%
Total equity$1.5B+31.7%
Total assets$3.2B-8.3%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$2.1M-95.2%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.76B-63.1%

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin4.6%+2.4pp
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-23.6%-28.5pp
Debt / equity0.1×0.0×
Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s prepaid & other current?
Sarepta Therapeutics, Inc. (SRPT) reported prepaid & other current of $187.97M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Sarepta Therapeutics, Inc.'s prepaid & other current increased by 78.2% year-over-year, from $105.48M to $187.97M.
What is the long-term trend for Sarepta Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s prepaid & other current has grown at a -4.2% compound annual growth rate (CAGR), from $213.32M to $171.86M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.